334 related articles for article (PubMed ID: 34450169)
1. Lipid poly (ɛ-caprolactone) hybrid nanoparticles of 5-fluorouracil for sustained release and enhanced anticancer efficacy.
Khan S; Aamir MN; Madni A; Jan N; Khan A; Jabar A; Shah H; Rahim MA; Ali A
Life Sci; 2021 Nov; 284():119909. PubMed ID: 34450169
[TBL] [Abstract][Full Text] [Related]
2. In vitro anti-leukemic assessment and sustained release behaviour of cytarabine loaded biodegradable polymer based nanoparticles.
Jan N; Madni A; Rahim MA; Khan NU; Jamshaid T; Khan A; Jabar A; Khan S; Shah H
Life Sci; 2021 Feb; 267():118971. PubMed ID: 33385406
[TBL] [Abstract][Full Text] [Related]
3. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
[TBL] [Abstract][Full Text] [Related]
4. Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery.
Tahir N; Madni A; Li W; Correia A; Khan MM; Rahim MA; Santos HA
Int J Pharm; 2020 May; 581():119275. PubMed ID: 32229283
[TBL] [Abstract][Full Text] [Related]
5. Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy.
Tahir N; Madni A; Correia A; Rehman M; Balasubramanian V; Khan MM; Santos HA
Int J Nanomedicine; 2019; 14():4961-4974. PubMed ID: 31308666
[No Abstract] [Full Text] [Related]
6. Physical PEGylation Enhances The Cytotoxicity Of 5-Fluorouracil-Loaded PLGA And PCL Nanoparticles.
Ashour AE; Badran M; Kumar A; Hussain T; Alsarra IA; Yassin AEB
Int J Nanomedicine; 2019; 14():9259-9273. PubMed ID: 31819428
[TBL] [Abstract][Full Text] [Related]
7. EGF-functionalized lipid-polymer hybrid nanoparticles of 5-fluorouracil and sulforaphane with enhanced bioavailability and anticancer activity against colon carcinoma.
Li S; Xu Z; Alrobaian M; Afzal O; Kazmi I; Almalki WH; Altamimi ASA; Al-Abbasi FA; Alharbi KS; Altowayan WM; Singh T; Akhter MH; Gupta M; Rahman M; Beg S
Biotechnol Appl Biochem; 2022 Oct; 69(5):2205-2221. PubMed ID: 34775646
[TBL] [Abstract][Full Text] [Related]
8. Formation and characterization of β-cyclodextrin (β-CD) - polyethyleneglycol (PEG) - polyethyleneimine (PEI) coated Fe3O4 nanoparticles for loading and releasing 5-Fluorouracil drug.
Prabha G; Raj V
Biomed Pharmacother; 2016 May; 80():173-182. PubMed ID: 27133054
[TBL] [Abstract][Full Text] [Related]
9. Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles.
Khan MM; Madni A; Tahir N; Parveen F; Khan S; Jan N; Ali A; Abdurrahim M; Farooq U; Khan MI
Int J Nanomedicine; 2020; 15():2207-2217. PubMed ID: 32280215
[TBL] [Abstract][Full Text] [Related]
10. Formulation, characterization and in vitro release study of 5-fluorouracil loaded chitosan nanoparticles.
Samy M; Abd El-Alim SH; Rabia AEG; Amin A; Ayoub MMH
Int J Biol Macromol; 2020 Aug; 156():783-791. PubMed ID: 32320805
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid-based nanoparticulate system for sustained release and enhanced in-vitro cytotoxic effect of 5-fluorouracil on skin Melanoma and squamous cell carcinoma.
Ali A; Madni A; Shah H; Jamshaid T; Jan N; Khan S; Khan MM; Mahmood MA
PLoS One; 2023; 18(2):e0281004. PubMed ID: 36854019
[TBL] [Abstract][Full Text] [Related]
12. 5-Fluorouracil-lipid conjugate: potential candidate for drug delivery through encapsulation in hydrophobic polyester-based nanoparticles.
Ashwanikumar N; Kumar NA; Asha Nair S; Vinod Kumar GS
Acta Biomater; 2014 Nov; 10(11):4685-4694. PubMed ID: 25110286
[TBL] [Abstract][Full Text] [Related]
13. Development and In Vitro Evaluation of Crizotinib-Loaded Lipid-Polymer Hybrid Nanoparticles Using Box-Behnken Design in Non-small Cell Lung Cancer.
Korucu Aktas P; Baysal I; Yabanoglu-Ciftci S; Arica B
AAPS PharmSciTech; 2023 Sep; 24(7):178. PubMed ID: 37658977
[TBL] [Abstract][Full Text] [Related]
14. Development of Perphenazine-Loaded Solid Lipid Nanoparticles: Statistical Optimization and Cytotoxicity Studies.
Farsani PA; Mahjub R; Mohammadi M; Oliaei SS; Mahboobian MM
Biomed Res Int; 2021; 2021():6619195. PubMed ID: 33997026
[TBL] [Abstract][Full Text] [Related]
15. Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: optimization,
Rizwanullah M; Perwez A; Mir SR; Alam Rizvi MM; Amin S
Nanotechnology; 2021 Jul; 32(41):. PubMed ID: 34198267
[TBL] [Abstract][Full Text] [Related]
16. Functionalized Lipid-Polymer Hybrid Nanoparticles Mediated Codelivery of Methotrexate and Aceclofenac: A Synergistic Effect in Breast Cancer with Improved Pharmacokinetics Attributes.
Garg NK; Tyagi RK; Sharma G; Jain A; Singh B; Jain S; Katare OP
Mol Pharm; 2017 Jun; 14(6):1883-1897. PubMed ID: 28402673
[TBL] [Abstract][Full Text] [Related]
17. Study of 5-Fluorouracil Loaded Chitosan Nanoparticles for Treatment of Skin Cancer.
Patel G; Yadav BKN
Recent Pat Nanotechnol; 2020; 14(3):210-224. PubMed ID: 31267881
[TBL] [Abstract][Full Text] [Related]
18. Di-Block PLCL and Tri-Block PLCLG Matrix Polymeric Nanoparticles Enhanced the Anticancer Activity of Loaded 5-Fluorouracil.
Ashour AE; Badran MM; Kumar A; Rishi AK; Yassin AE
IEEE Trans Nanobioscience; 2016 Oct; 15(7):739-747. PubMed ID: 28029617
[TBL] [Abstract][Full Text] [Related]
19. Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation.
Devrim B; Kara A; Vural İ; Bozkır A
Drug Dev Ind Pharm; 2016 Nov; 42(11):1865-76. PubMed ID: 27091346
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies.
Rehman M; Ihsan A; Madni A; Bajwa SZ; Shi D; Webster TJ; Khan WS
Int J Nanomedicine; 2017; 12():8325-8336. PubMed ID: 29200845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]